BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,673,000 | -58.5% | 8,675,000 | -55.7% | 0.04% | -47.0% |
| Q4 2017 | $23,289,000 | +164.4% | 19,581,000 | +161.7% | 0.07% | +144.4% |
| Q4 2016 | $8,807,000 | -26.3% | 7,483,000 | -21.6% | 0.03% | -25.0% |
| Q3 2016 | $11,953,000 | +85.0% | 9,548,000 | +71.6% | 0.04% | +80.0% |
| Q2 2016 | $6,460,000 | -47.2% | 5,563,000 | -45.8% | 0.02% | -47.4% |
| Q1 2016 | $12,230,000 | -6.2% | 10,272,000 | +5.7% | 0.04% | -2.6% |
| Q4 2015 | $13,033,000 | -5.6% | 9,717,000 | -5.1% | 0.04% | -7.1% |
| Q3 2015 | $13,806,000 | -30.1% | 10,236,000 | -17.3% | 0.04% | -19.2% |
| Q2 2015 | $19,763,000 | +7.2% | 12,371,000 | +2.0% | 0.05% | +10.6% |
| Q1 2015 | $18,432,000 | +178.5% | 12,131,000 | +101.6% | 0.05% | +176.5% |
| Q3 2014 | $6,619,000 | -49.4% | 6,017,000 | -51.3% | 0.02% | +13.3% |
| Q2 2014 | $13,070,000 | +95.3% | 12,352,000 | +105.8% | 0.02% | 0.0% |
| Q1 2014 | $6,692,000 | +1.9% | 6,002,000 | -1.8% | 0.02% | 0.0% |
| Q4 2013 | $6,569,000 | – | 6,114,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|